NSD2 and colorectal carcinoma: In summary, our results establish WHSC1 as an important cell-intrinsic regulator of antitumor immunity and suggest that pharmaceutical manipulation of WHSC1 may sensitize a subset of patients with CRC to immune checkpoint blockade.